Methods
DER
The ABIHR-II trial was a national prospective, randomized, multicenter non-AMG/MPG pilot study with two groups of patients (wearing an abdominal binder (AB) for 2 weeks during daytime vs. not wearing an AB following open IHR with the sublay technique. Patient enrollment took place from July 2020 to February 2022.The randomized clinical trial was conducted at the following hospitals: HELIOS Hospital Berlin-Buch (Germany), Otto-von-Guericke University Hospital Magdeburg (Germany), University Hospital Brandenburg an der Havel (Germany), Marien Hospital Düsseldorf (Germany), and Westpfalz Hospital Kaiserslautern (Germany).The study received primary approval from the Ethics Committee of the Berlin Medical Association on July 11, 2020 (Eth-09/20) and was conducted in accordance with the ethical standards of the Declaration of Helsinki 1975.An ethics vote was successfully obtained from all responsible German state medical associations (2022, Brandenburg; 2021, Rhineland-Palatinate; 2021, North Rhine Westphalia; 2020 Saxony Anhalt).The study was registered with the German Clinical Trials Registry (DRKS00017410) and funded by the 2020 Research Grant from the European Hernia Society.The ABIHR-II trial was conducted according to the CONSORT 2010 statement (Fig. The CONSORT 2010 flow chart of the ABIHR-II trial is depicted